Skip to main content
Quest Diagnostics

Neurological Complications of COVID-19

Date: Wednesday, Nov 18, 2020

Description: Presented by Dr. Michael K. Racke, MD. At the conclusion of this program, participants will be able to: Describe potential mechanisms for how SARS-CoV-2 enters the nervous system and affects cells, describe neurologic disorders secondary to COVID-19, including stroke and other neuroimmunological disorders, describe how COVID-19 affects clinical expression of other common comorbid neurological disorders. ASCLS P.A.C.E.® credits are available to laboratory professionals through May 18, 2021.

Author:

Racke, Michael K., MD
Medical Director of Neurology
Quest Diagnostics 

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.